Dilated cardiomyopathy (DCM) and myocarditis: Classification, clinical and autoimmune features

Applied Cardiopulmonary Pathophysiology

Volumn 16, Issue 1, 2012, Pages 82-95

  Caforio, Alida L P ^a   Bottaro, Stefania ^a   Iliceto, Sabino ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

Autoimmunity; Cardiac autoantibodies; Dilated cardiomyopathy; Inflammatory cardiomyopathies; Myocarditis

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); AUTOANTIBODY; AUTOANTIGEN; BETA ADRENERGIC RECEPTOR; CALCIUM CHANNEL L TYPE; CARDIAC MYOSIN; HEART ANTIBODY; HEAT SHOCK PROTEIN; HEAT SHOCK PROTEIN 60; HEAT SHOCK PROTEIN 70; HLA DR4 ANTIGEN; HLA DR5 ANTIGEN; MUSCARINIC RECEPTOR; MYOSIN HEAVY CHAIN; STRUCTURAL PROTEIN; TROPONIN I;

ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; CARDIOTOXICITY; CLINICAL FEATURE; CONGESTIVE CARDIOMYOPATHY; DISEASE CLASSIFICATION; ECHOCARDIOGRAPHY; EXTRACORPOREAL CIRCULATION; FAMILY; GENE MUTATION; GENETIC PREDISPOSITION; HEART DISEASE; HEART FAILURE; HEART MUSCLE BIOPSY; HEART MUSCLE CELL; HEART TRANSPLANTATION; HEART VENTRICLE FUNCTION; HUMAN; IMMUNIZATION; IMMUNOADSORPTION; IMMUNOFLUORESCENCE; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATORY INFILTRATE; MYOCARDITIS; PEDIGREE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SARCOLEMMA; SIGNAL TRANSDUCTION;

EID: 84857946167     PISSN: 09205268     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (61)

1. Richardson P, McKenna WJ, Bristow M et al. Report of the 1995 World Health Organization/ International Society and Federation of Cardiology Task Force on the definition and classification of cardiomyo - pathies. Circulation 1996; 93: 841-842
2. Jefferies JL, Towbin JA. Dilated cardiomyo - pathy. Lancet 2010; 375: 752-762
3. Aretz HT, Billingham ME, Edwards WE et al. Myocarditis: a histopathologic definition and classification. Am J Cardiol Pathol 1985; 1: 1-10
4. Magnani JW, Dec WG. Myocarditis. Current trends in diagnosis and treatment. Circulation 2006; 113; 876-90
5. Angelini A, Crosato M, Boffa GM et al. Active versus borderline myocarditis: clinicopathological correlates and prognostic implications. Heart 2002; 87: 210-215
6. Angelini A, Calzolari V, Calabrese F, Boffa GM, Maddalena F, Chioin R, Thiene G. Myo carditis mimicking acute myocardial infarction: role of endomyocardial biopsy in the differential diagnosis. Heart 2000; 84 (3): 245-50
7. Maisch B, Herzum M, Hufnagel G et al. Immunosuppressive and immunomodulatory treatment for myocarditis. Curr Opin Cardiol 1996; 11: 310-324
8. Yajima T, Knowlton KU. Viral myocarditis: from the perspective of the virus. Circulation 2009; 119: 2615-24
9. Calabrese F, Thiene G. Myocarditis and inflammatory cardiomyopathy: microbiological and molecular aspects. Cardiovascular Pathology 2003; 60: 11-25
10. Caforio ALP, Calabrese F, Angelini A, Tona F, Vinci A, Bottaro S, Ramondo A, Carturan E, Iliceto S, Thiene G, Daliento L. A prospective study of biopsy-proven myocarditis: prognostic relevance of clinical and etiopathogenetic features at diagnosis. Eur Heart J, 2007; 28 (11): 1326-33
11. Mason JW, O'Connell JB, Herskowitz A, Rose NR, McManus BM, Billingham ME, Moon TE, and the Myocarditis Treatment Trial Investigators. A clinical trial of immunosuppressive therapy for myocarditis. N Engl J Med 1995; 333: 269-275
12. Frustaci A, Chimenti C, Calabrese F, Pieroni M, Thiene G, Maseri A. Immunosuppressive therapy for active lymphocytic myocarditis: virological and immunologic profile of responders versus nonresponders. Circulation 2003; 107: 857-63
13. Wojnicz R, Nowalany-Kozielska E, Wojciechowska C et al. Randomized, placebo controlled study for immunosuppressive treatment of inflammatory dilated cardiomyopathy. Two-year follow-up results. Circulation 2001; 104: 39-45
14. Caforio ALP, Tona F, Vinci A, Calabrese F, Ramondo A, L Cacciavillani, Corbetti F, Leoni L, Thiene G, Iliceto S, Angelini A. Acute biopsy-proven lymphocytic myo - carditis mimicking Takotsubo cardiomyopathy. Eur J Heart Fail 2009; 11: 428-31
15. Cooper LT Jr, Hare JM, Tazelaar HD, Edwards WD, Starling RC, Deng MC, Menon S, Mullen GM, Jaski B, Bailey KR, Cunningham MW, Dec GW; Giant Cell Myocarditis Treatment Trial Investigators. Usefulness of immunosuppression for giant cell myocarditis. Am J Cardiol 2008; 102 (11): 1535-9
16. Caforio ALP, Tona F, Bottaro S, Vinci A, Daliento L, Thiene G, Iliceto S. Clinical implications of anti-heart autoantibodies in myocarditis and dilated cardiomyopathy. Autoimmunity 2008; 41 (1): 35-45
17. Rose NR. The significance of autoimmunity in myocarditis. In: Ernst Schering Research Foundation Workshop 55. Editors: HP Schultheiss, JF Kapp, Grotzbach G. Chronic viral and inflammatory cardiomyopathy. Berlin: Springer-Verlag, 2005: 169-93
18. Okazaki T, Honjo T. Pathogenic roles of cardiac autoantibodies in dilated cardio - myopathy. Trends in Molecular Medicine 2005; 11: 322-326
19. Caforio ALP, Keeling PJ, Zachara E et al. Evidence from family studies for autoimmunity in dilated cardiomyopathy. Lancet 1994; 344: 773-777
20. Caforio ALP, Mahon NG, Baig KM et al. Prospective familial assessment in dilated cardiomyopathy. Cardiac autoantibodies predict disease development in asymptomatic relatives. Circulation 2007; 115: 76-83
21. Limas CJ, Iakovis P, Anyfantakis A, Kroupis C, Cokkison DV. Familial clustering of autoimmune diseases in patients with dilated cardiomyopathy. Am J Cardiol 2004; 93: 1189-91
22. Mahon NG, Madden B, Caforio ALP et al. Immunohistochemical evidence of myocardial disease in apparently healthy relatives of patients with dilated cardiomyopathy. J Am Coll Cardiol 2002; 39: 455-462
23. Caforio ALP, Bonifacio E, Stewart JT et al. Novel organ-specific circulating cardiac autoantibodies in dilated cardiomyopathy. J Am Coll Cardiol 1990; 15: 1527-1534
24. Caforio ALP, Goldman JH, Haven AJ et al. Circulating cardiac autoantibodies as markers of autoimmunity in clinical and biopsyproven myocarditis. Eur Heart J 1997; 18: 270-275
25. Caforio ALP, Grazzini M, Mann JM et al. Identification of a and b cardiac myosin heavy chain isoforms as major autoantigens in dilated cardiomyopathy. Circulation 1992; 85: 1734-1742
26. Lauer B, Schannwell M, Kuhl U et al. Antimyosin autoantibodies are associated with deterioration of systolic and diastolic left ventricular function in patients with chronic myocarditis. J Am Coll Cardiol 2000; 35: 11-18
27. Warraich RS, Dunn MJ, Yacoub MH. Subclass specificity of autoantibodies against myosin in patients with idiopathic dilated cardiomyopathy: proinflammatory antibodies in dilated cardiomyopathy patients. Biochem Biophys Res Commun 1999; 259: 255-261
28. Wallukat G, Morwinski M, Kowal K et al. Antibodies against the b-adrenergic receptor in human myocarditis and dilated cardiomyopathy: b-adrenergic agonism without desensitization. Eur Heart J 1991; 12 (Suppl D): 178-181
29. Limas CJ, Limas C. β-receptor antibodies and genetics in dilated cardiomyopathy. Eur Heart J 1991; 12 (Suppl D): 175-177
30. 1-adrenoceptor with positive chronotropic effect. Circulation 1994; 89: 2760-2667
31. Jahns R, Boivin V, Krapf T et al. Modulation of b1-adrenoceptor activity by domain-specific antibodies and heart-failure associated autoantibodies. J Am Coll Cardiol 2000; 36: 1280-1287
32. Muller J, Wallukat G, Dandel M et al. Immunoglobulin adsorption in patients with idiopathic dilated cardiomyopathy. Circulation 2000; 101: 385-391
33. Staudt A, Bohm M, Knebel F et al. Potential role of autoantibodies belonging to the immunoglobulin G-3 subclass in cardiac dysfunction among patients with dilated cardiomyopathy. Circulation 2002; 106: 2448-2453
34. Caforio ALP, Wagner R, Gill JR et al. Organspecific cardiac autoantibodies: new serological markers for systemic hypertension in autoimmune polyendocrinopathy. Lancet 1991 337: 1111-15
35. Caforio ALP, Brucato A, Doria A, Brambilla G, Vinci A, Ghirardello A, Bottaro S, Tona F, Betterle C, Daliento L, Thiene G, Iliceto S. High frequency of circulating anti-heart and anti-intercalated disc autoantibodies: evidence for autoimmunity in idiopathic recurrent acute pericarditis. Heart 2010; 96: 779-84
36. MacLellan RW, Lusis AJ. Dilated cardiomyo - pathy: learning to live with yourself. Nat Med 2003; 9: 1455-1456
37. Rose NR. Viral damage or 'molecular mimicry'- placing the blame in myocarditis. Nature Med 2000; 6: 631-632
38. Warraich RS, Griffiths E, Falconar A, et al. Human cardiac myosin autoantibodies impair myocyte contractility: a cause-and-effect relationship. FASEB J 2006; 20: 651-660
39. Horwitz MS, La Cava A, Fine C et al. Pancreatic expression of interferon-g protects mice from lethal coxsackievirus B3 infection and subsequent myocarditis. Nature Med 2000; 6: 693-707.
40. Galvin JE, Hemric ME, Ward K et al. Cytotoxic mAb from rheumatic carditis recognizes heart valves and laminin. J Clin Invest 2000; 106: 217-224
41. Neu N, Rose NR, Beisel KW et al. Cardiac myosin induces myocarditis in genetically predisposed mice. J Immunol 1987; 139: 3630-3636
42. Smith SC, Allen PM (1991) Myosin-induced myocarditis is a T cell-mediated disease. J Immunol 1991; 147: 2141-2147
43. Kuan AP, Zuckier L, Liao L et al. Immunoglobulin isotype determines pathogenicity in antibody-mediated myocarditis in naïve mice. Circ Res 2000; 86: 281-285
44. Li Y, Heuser JS, Cunningham LC, Kosanke SD, Cunningham MW. Mimicry and antibody- mediated cell signaling in autoimmune myocarditis. J Immunol 2006; 177: 8234-8240.
45. Nishimira H et al. Autoimmune dilated cardiomyopathy in PD-1 receptor-deficient mice. Science 2001; 291: 319-322
46. Okazaki T, Tanaka Y, Nishio R et al. Autoantibodies against cardiac troponin I are responsible for dilated cardiomyopathy in PD- 1-deficient mice. Nat Med 2003; 9: 1477-1483
47. Schultheiss HP, Kuhl U, Schwimmbeck P et al Biomolecular changes in dilated cardiomyopathy. In: Baroldi G, Camerini F, Goodwin JF (eds). Advances in Cardiomyo - pathies. Springer Verlag, Berlin, 1990, pp. 221-234
48. Schultheiss HP, Ulrich G, Janda I et al. Antibody mediated enhancement of calcium permeability in cardiac myocytes. J Exp Med 1988; 168: 2105-2119
49. Jahns R, Boivin V, Hein L et al. Direct evidence for a b1-adrenergic receptor directed autoimmune attack as a cause of idiopathic dilated cardiomyopathy. J Clin Invest 2004; 113:1419-1429
50. Jahns R, Boivin V, Lohse MJ et al. b1-adrenergic receptor function, autoimmunity and pathogenesis of dilated cardiomyopathy. Trends Cardiovasc Med 2006; 16:20-24
51. Baba A, Yoshikawa T, Ogawa S. Autoantibodies against sarcolemmal Na-K-ATPase: possible upstream targets of arrhythmias and sudden death in patients with dilated cardiomyopathy. J Am Coll Cardiol 2002; 40: 1153-1159
52. Klein R, Maisch B, Kochsiek K et al. Demonstration of organ specific antibodies against heart mitochondria (anti-M7) in sera from patients with some forms of heart diseases. Clin Exp Immunol 1984; 58: 283-292
53. Ansari AA, Neckelmann N, Villinger F et al. Epitope mapping of the branched chain-ketoacid dehydrogenase dihydrolipoyl transacylase (BCKD-E2) protein that reacts with sera from patients with idiopathic dilated cardiomyopathy. J Immunol 1994; 153: 4754-4765
54. Fu LX, Magnusson Y, Bergh CH et al. Localization of a functional autoimmune epitope on the muscarinic acetylcholine receptor-2 in patients with idiopathic dilated cardio - myopathy. J Clin Invest 1993; 91: 1964-1968
55. Matsui S et al. Peptides derived from cardiovascular G-protein-coupled receptors induce morphological cardiomyopathic changes in immunized rabbits. J Mol Cell Cardiol 1997; 29: 641-655
56. Nikolaev VO, Boivin V, Störk S et al. A novel fluorescent method for the rapid detection of functional beta1-adrenergic receptor autoantibodies in heart failure. J Am Coll Cardiol 2007; 50: 423-431
57. Mobini R, Staudt A, Felix SB et al. Hemodynamic improvement and removal of autoantibodies against the b1-adrenergic receptor by immunoadsorption therapy in dilated cardiomyopathy. J Autoimmun 2003; 20: 345-350
58. Deubner N, Berliner D, Schlipp A et al, on behalf of the ETiCS-Study Group. Cardiac Beta1-Adrenoceptor Autoantibodies in Human Heart Disease: Rationale and Design of the Etiology, Titre-Course, and Survival (ETiCS) Study. Eur J Heart Fail 2009; 11: 428-31
59. Caforio ALP, Goldman JH, Baig KM et al. Cardiac autoantibodies in dilated cardio - myopathy become undetectable with disease progression. Heart 1997; 77: 62-67
60. Frustaci A, Russo MA, Chimenti C. Randomized study on the efficacy of immunosuppressive therapy in patients with virus-negative inflammatory cardiomyopathy: the TIMIC study. Eur Heart J 2009; 30: 1995-2002
61. Felix SB. Staudt A, Landsberger M et al. (2002) Removal of cardiodepressant antibodies in dilated cardiomyopathy by immunoadsorption. J Am Coll Cardiol 39: 646-652